ERENDOR, F. Et Al. 2021. Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation. GENE THERAPY , vol.28, no.3-4 , 130-141.

ERENDOR, F., Sahin, E. O., ŞANLIOĞLU, A. D., BALCI, M. K., Griffith, T. S., & ŞANLIOĞLU, S., (2021). Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation. GENE THERAPY , vol.28, no.3-4, 130-141.

ERENDOR, FULYA Et Al. "Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation," GENE THERAPY , vol.28, no.3-4, 130-141, 2021

ERENDOR, FULYA E. Et Al. "Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation." GENE THERAPY , vol.28, no.3-4, pp.130-141, 2021

ERENDOR, F. Et Al. (2021) . "Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation." GENE THERAPY , vol.28, no.3-4, pp.130-141.

@article{article, author={FULYA ERENDOR CİHAN Et Al. }, title={Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation}, journal={GENE THERAPY}, year=2021, pages={130-141} }